146 related articles for article (PubMed ID: 34119588)
1. Letter to the editor of radiotherapy and oncology regarding of the paper "Radiotherapy enhances uptake and efficacy of
Chen J; Liu G
Radiother Oncol; 2021 Aug; 161():260. PubMed ID: 34119588
[No Abstract] [Full Text] [Related]
2. In reply to the Letter to the Editor by Chen and Lui regarding "Radiotherapy enhances uptake and efficacy of
Dietrich A; Andreeff M; Koi L; Bergmann R; Schubert M; Schreiner L; Löck S; Sihver W; Freudenberg R; Hering S; Pietzsch HJ; Steinbach J; Kotzerke J; Baumann M; Krause M
Radiother Oncol; 2021 Aug; 161():261-262. PubMed ID: 34119587
[No Abstract] [Full Text] [Related]
3. Letter to the Editor of Radiotherapy and Oncology regarding the paper entitled "50 years of radiotherapy research: Evolution, trends and lessons for the future" by Berger et al. (December 2021, Volume 165).
Tuscano C; Al Sayyad S; Sceni G
Radiother Oncol; 2022 Jul; 172():149-150. PubMed ID: 35413390
[No Abstract] [Full Text] [Related]
4. Response to Letter to the Editor of Radiotherapy and Oncology regarding the paper entitled "50 years of radiotherapy research: Evolution, trends and lessons for the future" by Berger et al. (December 2021, volume 165).
Berger T; Noble DJ; Shelley LEA; Hopkins KI; McLaren DB; Burnet NG; Nailon WH
Radiother Oncol; 2022 Jul; 172():151-152. PubMed ID: 35398383
[No Abstract] [Full Text] [Related]
5. Letter to the editor of radiotherapy and oncology regarding the article esposito et al: Estimating dose delivery accuracy in stereotactic body radiation therapy: A review of in-vivo measurement methods.
Kos S
Radiother Oncol; 2020 Dec; 153():319. PubMed ID: 32653600
[No Abstract] [Full Text] [Related]
6. Response letter to the Editor of Radiotherapy and Oncology regarding the paper "Stereotactic body radiotherapy for head and neck skin cancer" by IS Voruganti et al.
Karam I; Voruganti IS; Poon I
Radiother Oncol; 2022 May; 170():248-249. PubMed ID: 35278592
[No Abstract] [Full Text] [Related]
7. Letter to the editor of radiotherapy and oncology regarding of the paper "Stereotactic body radiotherapy for head and neck skin cancer" by IS Voruganti et al.
Pergolizzi S; Ferini G; Parisi S
Radiother Oncol; 2022 May; 170():247. PubMed ID: 35278593
[No Abstract] [Full Text] [Related]
8. Radiotherapy enhances uptake and efficacy of
Dietrich A; Andreeff M; Koi L; Bergmann R; Schubert M; Schreiner L; Löck S; Sihver W; Freudenberg R; Hering S; Pietzsch HJ; Steinbach J; Kotzerke J; Baumann M; Krause M
Radiother Oncol; 2021 Feb; 155():285-292. PubMed ID: 33227356
[TBL] [Abstract][Full Text] [Related]
9. Letter to the Editor of Radiotherapy and Oncology regarding the paper titled "MRI and FUNDUS image fusion for improved ocular biometry in Ocular Proton Therapy" by Via et al.
Beenakker JM; Rasch CRN
Radiother Oncol; 2022 Nov; 176():251. PubMed ID: 35988772
[No Abstract] [Full Text] [Related]
10. Response to "Letter to the Editor of Radiotherapy and Oncology regarding the paper titled "MRI and FUNDUS image fusion for improved ocular biometry in Ocular Proton Therapy" by Via et al.".
Via R; Fattori G; Pica A; Paganelli C; Lomax A; Schalenbourg A; Weber DC; Baroni G; Hrbacek J
Radiother Oncol; 2022 Nov; 176():252. PubMed ID: 35988774
[No Abstract] [Full Text] [Related]
11. Response to the letter to the editor by Macià i Garau et al. regarding the article "ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma" by Niyazi et al.
Niyazi M; Bendszus M; Minniti G
Radiother Oncol; 2024 Jan; 190():109965. PubMed ID: 37922992
[No Abstract] [Full Text] [Related]
12. Management of radiation dermatitis in patients receiving cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: proposals for a revised grading system and consensus management guidelines.
Bernier J; Russi EG; Homey B; Merlano MC; Mesía R; Peyrade F; Budach W
Ann Oncol; 2011 Oct; 22(10):2191-200. PubMed ID: 21606209
[TBL] [Abstract][Full Text] [Related]
13. Letter to the Editor of Radiotherapy and Oncology regarding the paper entitled "Prospective Data Registration and Clinical Trials for Particle Therapy" by Langendijk et al.
Laprie A; Bernier V; Carrie C;
Radiother Oncol; 2019 Jan; 130():193. PubMed ID: 30360997
[No Abstract] [Full Text] [Related]
14. Letter to the editor regarding Mackillop et al., IJROBP 32:531-539; 1995.
Rose CM
Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):239-40. PubMed ID: 7642428
[No Abstract] [Full Text] [Related]
15. From the Guest Editor: New Lenses, New Visions for Radiotherapy in the Molecular-Genetic-Immunomodulator Era of Oncology.
Kavanagh BD
Cancer J; 2016; 22(4):245-6. PubMed ID: 27441743
[No Abstract] [Full Text] [Related]
16. In reply to the letter to the editor: "In reply to Fiorino et al: The central role of the radiation oncologist in the multidisciplinary and multiprofessional model of modern radiation therapy".
Fiorino C; Jeraj R; Clark CH; Garibaldi C; Georg D; Muren L; van Elmpt W; Bortfeld T; Jornet N
Radiother Oncol; 2021 Feb; 155():e22-e23. PubMed ID: 33412208
[No Abstract] [Full Text] [Related]
17. Letter to the Editor regarding "The tubarial salivary glands: A potential new organ at risk for radiotherapy".
Nascimento JJC; Ribeiro ECO; Silva-Neto EJ
Radiother Oncol; 2021 Jan; 154():323. PubMed ID: 33310000
[No Abstract] [Full Text] [Related]
18. Grading system and management guidelines for dermatitis induced by head and neck radiotherapy plus cetuximab: clinical validation required.
Langendijk JA; Oosting SF
Ann Oncol; 2011 Oct; 22(10):2157-9. PubMed ID: 21878428
[No Abstract] [Full Text] [Related]
19. Letter to the editor concerning Valstar et al., [Radiother Oncol 2020 Sep 23;S0167-8140(20)30809-4. doi: 10.1016/j.radonc.2020.09.034].
Bikker FJ; Vissink A
Radiother Oncol; 2021 Jan; 154():318. PubMed ID: 33309998
[No Abstract] [Full Text] [Related]
20. No convincing evidence for the presence of tubarial salivary glands: A letter to the editor regarding "The tubarial salivary glands: A potential new organ at risk for radiotherapy".
Iwanaga J; Ibaragi S; Nakano K; Takeshita Y; Tubbs RS
Radiother Oncol; 2021 Jan; 154():321-322. PubMed ID: 33310009
[No Abstract] [Full Text] [Related]
[Next] [New Search]
